These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2905267)

  • 1. Differential effects of EEDQ on the dopamine D-1 receptor in vivo and in vitro.
    Andersen PH
    Eur J Pharmacol; 1988 Jul; 152(1-2):153-6. PubMed ID: 2905267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW; Creese I
    Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D; Di Paolo T
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR
    Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of D-1 dopamine receptors facilitates D-2 dopamine receptor recovery after irreversible receptor blockade.
    Cameron DL; Crocker AD
    Neuropharmacology; 1988 Apr; 27(4):447-50. PubMed ID: 2901675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo binding of SCH 39166: a D-1 selective antagonist.
    McQuade RD; Duffy RA; Coffin VL; Chipkin RE; Barnett A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):42-9. PubMed ID: 1826927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
    Nowak G; Arnt J; Hyttel J
    Eur J Pharmacol; 1988 Aug; 153(2-3):309-11. PubMed ID: 3053212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum.
    Norman AB; Wachendorf TJ; Sanberg PR
    Life Sci; 1989; 44(13):831-6. PubMed ID: 2648096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic SCH 23390 or acute EEDQ on the discriminative stimulus effects of SKF 38393.
    Cao GH; Perry BD; Woolverton WL
    Pharmacol Biochem Behav; 1992 Feb; 41(2):321-7. PubMed ID: 1349436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA; Rowlett JK; McDougall SA; Bardo MT
    Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of dopamine binding sites and changes in dopamine and dihydroxyphenylacetic acid levels in 17- and 90-day-old rat striatum after irreversible receptor antagonism.
    Crawford CA; McDougall SA; Rowlett JK; Bardo MT
    Neurosci Lett; 1992 Mar; 137(2):265-9. PubMed ID: 1350079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O; Parkinson D; Nielsen M
    Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation.
    Battaglia G; Norman AB; Creese I
    Eur J Pharmacol; 1988 Jan; 145(3):281-90. PubMed ID: 2895004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a fast receptor turnover of D1 dopamine receptors in various forebrain regions of the rat.
    Fuxe K; Agnati LF; Merlo Pich E; Meller E; Goldstein M
    Neurosci Lett; 1987 Oct; 81(1-2):183-7. PubMed ID: 3320818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.